Historique
Auteur A. PIRONA
Documents disponibles écrits par cet auteur (20)
Ajouter le résultat à votre sélection Affiner la recherche
I. GIRAUDON ; D. HEDRICH ; A. PIRONA ; A. NOOR ; J. MOUNTENEY | 2018
Dans Swaps (n°88-89, 1er et 2e trimestre 2018) Article : PériodiqueFRANÇAIS : Avec au moins 9 100 overdoses, ou décès provoqués par la drogue, en Europe en 2016 - en augmentation de 4% depuis 2015 - la consommation de drogues illicites représente un véritable défi de santé public (EMCDDA European Drug Report 2[...]
FRANÇAIS : Bien que l'usage de NPS en Europe demeure relativement faible, l'EMCDDA s'alarme des risques liés à la consommation de ces substances. Les données récentes mettent en évidence que les NPS sont à l'origine d'urgences hospitalières et [...]
J. STRANG ; T. GROSHKOVA ; A. UCHTENHAGEN ; W. VAN DEN BRINK ; C. HAASEN ; M. T. SCHECHTER ; N. LINTZERIS ; J. BELL ; A. PIRONA ; E. OVIEDO-JOEKES ; R. SIMON ; N. METREBIAN | 2015
Dans British Journal of Psychiatry (Vol.207, n°1, July 2015) Article : PériodiqueBACKGROUND: Supervised injectable heroin (SIH) treatment has emerged over the past 15 years as an intensive treatment for entrenched heroin users who have not responded to standard treatments such as oral methadone maintenance treatment (MMT) or[...]
OEDT = EMCDDA ; A. PIRONA ; L. MONTANARI ; I. GIRAUDON ; J. MATIAS ; K. OIEN ; L. VANDAM ; T. SURMONT ; B. GUARITA ; F. MATHIS ; J. MOUNTENEY ; K. NATONIEWSKA ; S. SLEIMAN ; P. GRIFFITHS | 2021
RapportSince early 2020, the COVID-19 pandemic has had a dramatic impact on the way we live, with European countries having to introduce unprecedented measures to protect public health. As with all areas of life, drug consumption, related harms and dru[...]
ENGLISH : This report provides a comprehensive review of the relatively new phenomenon of Internet-based drug treatment interventions (DTI). It presents a sample of Internet-based DTI programmes across Europe and outlines their methodologies, [...]
G. QUAGLIO ; A. PIRONA ; G. ESPOSITO ; T. KARAPIPERIS ; H. BRAND ; G. DOM ; L. BERTINATO ; L. MONTANARI ; F. KIEFER ; G. CARRA | 2019
Dans Drugs: Education, Prevention and Policy (Vol.26, n°5, October 2019) Article : PériodiqueBackground: Little is known about the knowledge and use of technology-based interventions (TBIs) by health personnel working in the addiction field across Europe. Methods: An online questionnaire was designed using SurveyMonkey® in order to det[...]
This paper presents results from a scoping study on the availability of smartphone-based applications in the drugs field within a European and global context. It explores the range of m-health applications available to users and professionals s[...]Nouveauté
A. PIRONA ; A. BO ; D. HEDRICH ; M. FERRI ; N. VAN GELDER ; I. GIRAUDON ; L. MONTANARI ; R. SIMON ; J. MOUNTENEY | 2017
Dans International Journal of Drug Policy (Vol.40, February 2017) Article : PériodiqueBackground: The availability of new psychoactive substances (NPS) in Europe has rapidly increased over the last decade. Although prevalence levels of NPS use remain low in the general European population, there are serious concerns associated wi[...]
OEDT = EMCDDA ; L. VANDAM ; P. BORLE ; L. MONTANARI ; T. SURMONT ; A. PIRONA ; D. HEDRICH ; A. GALLEGOS ; N. SINGLETON ; J. MOUNTENEY ; P. GRIFFITHS | 2018
RapportThis report looks at the use of new psychoactive substances (NPS) in prison settings. This is a rapidly developing phenomenon, but empirical data are currently scarce and patchy. There is growing evidence that NPS are responsible for a large sha[...]Nouveauté
J. MOUNTENEY ; P. GRIFFITHS ; A. BO ; A. CUNNINGHAM ; J. MATIAS ; A. PIRONA | 2018
Dans International Journal of Drug Policy (Vol.51, January 2018) Article : PériodiqueThis paper explores the recent resurgence in use of ecstasy/MDMA in Europe and highlights keys areas of continuity and divergence between the ecstasy market of the 1990s and the current MDMA market. Based on a scoping study involving a targeted [...]
OEDT = EMCDDA ; J. MOUNTENEY ; A. BO ; A. CUNNINGHAM ; I. GIRAUDON ; J. MATIAS ; A. PIRONA ; N. VAN GELDER ; A. RYBARSKA ; L. VANDAM ; P. GRIFFITHS | 2016
RapportThis report explores the recent resurgence in use of MDMA in Europe and increased availability of high-strength MDMA tablets, crystals and powders. It notes that the picture is not uniform across European countries, and while overall the region’[...]
L. MONTANARI ; M. PASINETTI ; B. GUARITA ; L. ROYUELA ; K. MULLIGAN ; J. VICENTE ; D. KLEMPOVA ; A. PIRONA ; A. GYARMATHY | 2013
Dans Drugs: Education, Prevention and Policy (Vol.20, n°1, February 2013) Article : PériodiqueThe aim of this article is to explore the prevalence of primary illicit stimulant use among people who enter drug treatment in Europe. Drawing on information provided by European Union treatment centres in 2009 (excluding Latvia, Lithuania, Port[...]
L. MONTANARI ; A. PIRONA ; B. GUARITA ; D. HEDRICH ; J. MOUNTENEY ; J. VICENTE | 2019
Dans Journal of Studies on Alcohol and Drugs (Suppl.18, January 2019) Article : PériodiqueENGLISH: OBJECTIVE: The article describes an epidemiological indicator called Treatment Demand Indicator (TDI). The TDI aims to provide professionals and researchers with a common European methodology for collecting and reporting core data on d[...]
L. MONTANARI ; R. TELTZROW ; S. VANMALDEREN ; R. RANIERI ; J. A. MARTIN PELAEZ ; L. VANDAM ; J. MOUNTENEY ; A. PIRONA ; F. MEROUEH ; I. GIRAUDON ; J. MATIAS ; K. SKARUPOVA ; L. ROYUELA ; J. MOREL D'ARLEUX | 2021
Dans International Journal of Prisoner Health (Vol.17, n°3, 2021) Article : PériodiquePurpose: This paper aims to describe the impact of the COVID-19 containment measures on the provision of drug treatment and harm reduction services in European prisons in15 countries during the early phase of the pandemic (March-June 2020). Des[...]
HUXSTER J. K. ; A. PIRONA ; M. J. MORGAN | 2006
Dans Journal of Psychopharmacology (Vol.20, n°2, 2006) Article : PériodiqueAll previous studies of the sub-acute effects of ecstasy have failed to adequately control for group differences in psychopathology and past and concurrent substance use. The present study was designed to avoid these limitations. At an initial p[...]
